Advocates say microdosing reduces costs and side effects while maintaining weight loss, then can help with weight maintenance. The approach is especially popular among telemedicine physicians, who ...
A recent review shows who newer medications for type 2 diabetes may help the most, particularly in reducing the risk of cardiovascular disease.
Novo Nordisk's CEO is not worried about blockbuster semaglutide drugs being added to Medicare drug pricing negotiations this ...
Cencora Enjoys Growth Momentum From GLP-1s, Healthy Utilization Trends, and Growing Specialty Assets
Cencora simplifies distribution logistics by shipping products to centralized wholesaler locations, as opposed to shipping directly to pharmacies and various customer locations. Additionally, Cencora ...
Jim Cramer, the host of Mad Money, discussed the upcoming market and corporate activity to look forward to this week, which ...
Websites that sell compounded glucagon-like peptide-1 receptor agonists (GLP-1 RAs) often partially inform or misinform consumers.
Tricia Rodriguez, Truveta senior applied research scientist & lead study author, explains the study findings concerning why ...
Scouted selects products independently. If you purchase something from our posts, we may earn a small commission. Unless you ...
Approximately 15.5 million Americans have been or currently are on injectable diabetes or weight-loss medications known as ...
Bloomfield-based Cigna announced this week a new initiative that aims to reduce out-of-pocket prescription-drug costs and make those costs more transparent.
The Medicines and Healthcare Products Regulatory Agency (MHRA) has ruled that warnings about the risk should now be added to ...
Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results